Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.83 M
About Calithera Biosciences, Inc.
Sector
Industry
CEO
Susan M. Molineaux
Website
Headquarters
South San Francisco
Founded
2010
FIGI
BBG0071GQ6D1
Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. It also focuses on researching small molecule oncology compounds with a biomarker-driven approach that targets genetic vulnerabilities in cancer cells to deliver new therapies for patients suffering from aggressive hematologic. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CALA is 0.0070 USD — it has increased by 16.67% in the past 24 hours. Watch Calithera Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Calithera Biosciences, Inc. stocks are traded under the ticker CALA.
CALA stock has risen by 250.00% compared to the previous week, the month change is a 600.00% rise, over the last year Calithera Biosciences, Inc. has showed a −78.46% decrease.
CALA reached its all-time high on Dec 15, 2014 with the price of 33.4800 USD, and its all-time low was 0.0001 USD and was reached on Aug 26, 2024. View more price dynamics on CALA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CALA stock is 14.29% volatile and has beta coefficient of −2.06. Track Calithera Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Calithera Biosciences, Inc. there?
Today Calithera Biosciences, Inc. has the market capitalization of 34.11 K, it has decreased by −40.00% over the last week.
Yes, you can track Calithera Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Calithera Biosciences, Inc. is going to release the next earnings report on Nov 15, 2024. Keep track of upcoming events with our Earnings Calendar.
No, CALA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CALA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Calithera Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Calithera Biosciences, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Calithera Biosciences, Inc. stock shows the sell signal. See more of Calithera Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.